LSD Anxiety Win; Pimavanserin Schizophrenia Flop; 'Bright Light' for Depression?

(MedPage Today) -- In a phase IIb study, a single dose of an investigational LSD-containing drug (MM120) led to significantly greater reductions in 12-week scores on the Hamilton Anxiety Rating Scale compared with placebo, according to Mind Medicine...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news